The Italian Medicines Agency's latest expenditure report reveals a significant overspend on medicines for the first third of the year, driven primarily by costs for new cancer drugs and cardiovascular therapies.
Outpatient budget protection, or ‘practice special features’ (Praxisbesonderheiten), is used within German statutory health insurance to prevent prescribers being financially penalised for clinically appropriate but atypically high medicine costs.
